The expression of mTOR, which is a key regulator in cell survival, was correlated with tumor stages in clinical-pathological study, whereas the suppression of mTOR and its downstream S6K reduced growth in OSCC cells [33]. The gene discussed is RPS6KB1; the disease is neoplasm.